Less Ads, More Data, More Tools Register for FREE

Pin to quick picksServelec Group Regulatory News (SERV)

  • There is currently no data for SERV

Trading Statement

5 Nov 2007 07:01

Servocell Group PLC05 November 2007 SERV.L 5 November 2007 SERVOCELL GROUP PLC ("SERVOCELL" OR THE "COMPANY") Since the interim results statement released on 28 September 2007, the Board hascontinued to monitor revenue projections and cash flow forecasts for the Group. The Company has successfully completed further development and testing on itsActive Latch component, the AL2 module and the move into volume production hascommenced. The AL2 is a critical component of the Company's first "Ready to Go"product, the CL2, production of which should commence when the AL2 componentsbecome available, enabling the delivery of initial CL2 orders. The Board arepleased to announce that market reaction to the CL2 product has beenencouraging. The Directors anticipate that, following delivery of initial ordersto the Company's distributors, combined with marketing activities to achieve"pull through", there will be a growing level of sales. The Board is now focussed on securing additional financing to provide sufficientworking capital to allow the Company to continue to trade. The Directors haveprepared revenue and working capital projections which predict a peak cashrequirement in the order of £4.0 million over the next 30 months, by which timethe Directors expect the Company to be cash-flow positive on a monthly basis.The Board has worked with a number of parties to explore the funding optionsavailable to the Company and continues so to do. However, if additional fundingis not secured or shareholder value is otherwise realised before the end of2007, the Board expects that the Group would be required to cease trading. The Board's current assessment is that the most likely avenue for securingadditional funding is a placing of new ordinary shares ("the Placing"). TheBoard has received commitments from Greenbrook Industries Limited("Greenbrook"), subject to certain conditions, whereby Greenbrook will convert(on Admission of all new ordinary shares the subject of the Placing) alloutstanding balances of the loan due to it at that date into new ordinary sharesat the Placing price, thereby relinquishing any security over the Company'sassets. Greenbrook have also committed to accepting a placing participation ofup to £500,000 of new ordinary shares as part of any placing. All of theseshares will rank pari passu in all respects with the Company's existing ordinaryshares. It is emphasised that there can be no certainty at this stage that a Placing canbe successfully completed, nor that any other form of financing could beobtained in the event that a Placing cannot be successfully completed. A further announcement will be made when appropriate. For further information please contact: Mike Hartley, Executive Chairman, Servocell Group plc 07711 734631Gregor Paterson, Analyst, Brewin Dolphin 0845 213 4211Jon Fitzpatrick, Corporate Finance (NOMAD), Brewin Dolphin 0845 213 4222 About Servocell Servocell is a provider of Active Latch technology that controls with low energyinputs the movement or motion of mechanisms, such as locks. The Group's devicesare underpinned by piezo ceramic actuators, which are well established in manyapplications such as reversing sensors for motor vehicles. Through significantinvestment, Servocell has developed a unique methodology for creating actuatorswhich give relatively large movement at a low power input. The Company hasapplied this technology into modules under the Active Latch brand for sale intolock manufacturers' products. More recently, to fully exploit application of the technology, the Group hasbeen developing a range of "Ready to Go" products under the Cabinet Latch andActive Escutcheon brands. These are being sold primarily through majordistributors and where appropriate as private label lock manufacturer'sproducts. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Mar 201412:04 pmRNSHolding(s) in Company
12th Mar 20147:00 amRNSFinal year results - 31 December 13
3rd Mar 20142:09 pmRNSHolding(s) in Company
17th Feb 20147:00 amRNSServelec Healthcare Contract Wins
15th Jan 20147:00 amRNSPost Year End Trading Statement
16th Dec 20131:28 pmRNSHolding(s) in Company
12th Dec 201311:46 amRNSReplacement - Holding(s) in Company
6th Dec 201312:32 pmRNSReplacement - Holding(s) in Company
6th Dec 201310:49 amRNSHolding(s) in Company
5th Dec 20134:28 pmRNSHolding(s) in Company
5th Dec 20134:28 pmRNSHolding(s) in Company
5th Dec 20134:27 pmRNSHolding(s) in Company
5th Dec 20134:27 pmRNSHolding(s) in Company
5th Dec 20134:25 pmRNSHolding(s) in Company
3rd Dec 201311:43 amRNSHolding(s) in Company
2nd Dec 20138:00 amRNSAdmission to Trading on the London Stock Exchange
14th Dec 200712:41 pmRNSAdministration Order
10th Dec 20078:45 amRNSTemporary Suspension
10th Dec 20078:45 amRNSSuspension - Servocell Group
5th Nov 20077:01 amRNSTrading Statement
28th Sep 20077:05 amRNSInterim Results
23rd Aug 200710:49 amRNSRelated Party Transaction
15th Aug 20071:26 pmRNSAIM Rule 26
9th Aug 20077:01 amRNSTrading Update
2nd Jul 20071:31 pmRNSInterim CFO
22nd Jun 20074:21 pmRNSDirectorate Change
30th May 20077:01 amRNSTrading Update
22nd May 20077:01 amRNSNew ProActive Partner
4th May 20077:00 amRNSBoard Appointment
30th Apr 20077:02 amRNSContract Win
5th Apr 20073:20 pmRNSHolding(s) in Company
5th Apr 20073:18 pmRNSHolding(s) in Company
5th Apr 20073:15 pmRNSHolding(s) in Company
5th Apr 20073:12 pmRNSHolding(s) in Company
5th Apr 20073:10 pmRNSHolding(s) in Company
4th Apr 20071:32 pmRNSHolding(s) in Company
29th Mar 20074:59 pmRNSHolding(s) in Company
29th Mar 20073:13 pmRNSHolding(s) in Company
29th Mar 20077:01 amRNSDirector/PDMR Shareholding
26th Mar 20077:01 amRNSPreliminary Results
19th Dec 20061:08 pmRNSTotal Voting Rights
12th Dec 20067:00 amRNSDistribution Deal
7th Nov 20067:00 amRNSAppointment of Sales Director
23rd Oct 20067:00 amRNSDTI Funded Project
26th Sep 20064:24 pmRNSHolding(s) in Company
18th Sep 20067:01 amRNSInterim Results
19th Jun 20067:00 amRNSBeloxx Contract
24th May 200610:18 amRNSPolice Adopt New Technology
9th May 200610:45 amRNSNew Technology Application
2nd May 20067:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.